These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 36435362)
1. Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights. Oliyaei N; Moosavi-Nasab M; Tanideh N; Iraji A Brain Res Bull; 2023 Feb; 193():11-21. PubMed ID: 36435362 [TBL] [Abstract][Full Text] [Related]
2. Natural Carotenoids as Neuroprotective Agents for Alzheimer's Disease: An Evidence-Based Comprehensive Review. Batool Z; Chen JH; Gao Y; Lu LW; Xu H; Liu B; Wang M; Chen F J Agric Food Chem; 2022 Dec; 70(50):15631-15646. PubMed ID: 36480951 [TBL] [Abstract][Full Text] [Related]
3. In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ Alghazwi M; Smid S; Musgrave I; Zhang W Neurochem Int; 2019 Mar; 124():215-224. PubMed ID: 30639263 [TBL] [Abstract][Full Text] [Related]
4. Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis. Lakey-Beitia J; Kumar D J; Hegde ML; Rao KS Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31703296 [TBL] [Abstract][Full Text] [Related]
5. A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease. Singh YP; Rai H; Singh G; Singh GK; Mishra S; Kumar S; Srikrishna S; Modi G Eur J Med Chem; 2021 Apr; 215():113278. PubMed ID: 33662757 [TBL] [Abstract][Full Text] [Related]
6. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease. Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies. Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease. Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045 [TBL] [Abstract][Full Text] [Related]
10. Management of oxidative stress and other pathologies in Alzheimer's disease. Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798 [TBL] [Abstract][Full Text] [Related]
11. Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review. Singh A; Kumar Singh N Curr Pharm Biotechnol; 2024; 25(9):1112-1123. PubMed ID: 37526460 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside. Islam F; Nafady MH; Islam MR; Saha S; Rashid S; Akter A; Or-Rashid MH; Akhtar MF; Perveen A; Md Ashraf G; Rahman MH; Hussein Sweilam S Mol Neurobiol; 2022 Jul; 59(7):4384-4404. PubMed ID: 35545730 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease. Han J; Du Z; Lim MH Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227 [TBL] [Abstract][Full Text] [Related]
14. Artemether Activation of AMPK/GSK3 Li S; Zhao X; Lazarovici P; Zheng W Oxid Med Cell Longev; 2019; 2019():1862437. PubMed ID: 31871541 [TBL] [Abstract][Full Text] [Related]
15. Fucoxanthin, a Marine Carotenoid, Attenuates Lin J; Yu J; Zhao J; Zhang K; Zheng J; Wang J; Huang C; Zhang J; Yan X; Gerwick WH; Wang Q; Cui W; He S Oxid Med Cell Longev; 2017; 2017():6792543. PubMed ID: 28928905 [TBL] [Abstract][Full Text] [Related]
16. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential. Angelopoulou E; Piperi C Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064 [TBL] [Abstract][Full Text] [Related]
17. Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review. Lee JY; Wong CY; Koh RY; Lim CL; Kok YY; Chye SM Yale J Biol Med; 2024 Jun; 97(2):205-224. PubMed ID: 38947104 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice. Ahmad A; Ali T; Park HY; Badshah H; Rehman SU; Kim MO Mol Neurobiol; 2017 Apr; 54(3):2269-2285. PubMed ID: 26944285 [TBL] [Abstract][Full Text] [Related]
19. Small Molecule Natural Products and Alzheimer's Disease. Wu X; Cai H; Pan L; Cui G; Qin F; Li Y; Cai Z Curr Top Med Chem; 2019; 19(3):187-204. PubMed ID: 30714527 [TBL] [Abstract][Full Text] [Related]
20. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities. Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]